Zevra Therapeutics Inc.
ZVRA | NASDAQ
$11.58
-$0.09 (-0.77%)
At close: Sep 22, 2026, 4:00 PM ET
$11.44
-$0.23 (-1.97%)
Pre-market:
Sep 22, 2026, 8:56 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 94.58M | 122.65M | 83.23M | 35.33M | 2.64M | -91.99M | -105.51M | -84.93M | -65.75M | -48.39M | -44.99M | -24.09M | -16.66M | -38.13M | -26.77M | -35.23M | -30.37M | -123K | -8.56M | -10.71M | -11.96M | -17.3M |
Depreciation & Amortization | 1.85M | 2.77M | 4.05M | 5.34M | 6.57M | 6.48M | 6.39M | 5.53M | 3.97M | 2.49M | 1.01M | 519K | 855K | 958K | 944K | 708K | 375K | 258K | 257K | 259K | 261K | 265K |
Stock-Based Compensation | 16.23M | 12.62M | 12.63M | 12.37M | 15.73M | 15.9M | 14.91M | 13.85M | 9.1M | 8.62M | 7.45M | 4.48M | 4.01M | 3.37M | 3.34M | 4.16M | 3.87M | 2.68M | 2.44M | 2.07M | 1.84M | 2.14M |
Other Working Capital | 7.12M | 3.03M | 2.36M | 3.62M | 3.56M | 3.09M | 1.03M | 2.31M | 2.27M | 1.47M | 3.44M | 8.34M | 8.21M | 6.28M | 3.09M | -698K | -3.18M | -1.22M | -295K | -764K | 410K | -329K |
Other Non-Cash Items | -79.06M | -117.46M | -78.45M | -64.71M | -61.99M | 13.4M | 14.55M | 7.55M | 5.75M | 5.66M | 9.89M | -9.11M | -14.7M | 5.17M | 4.18M | 18.19M | 17.74M | -328K | 16.66M | 18.45M | 20.63M | 22.89M |
Deferred Income Tax | 68K | 2.27M | 3.45M | 2.95M | 3.38M | 1.18M | n/a | -6.63M | -12.19M | -12.19M | -12.19M | -5.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 5.87M | -10.08M | -26.51M | -14.63M | -12.55M | -6.7M | n/a | -4.95M | 3.05M | -1.84M | 5.3M | 11.91M | 2.68M | 9.36M | -406K | -2.93M | -2.86M | 7.05M | -357K | 158K | 1.14M | -10.49M |
Operating Cash Flow | 39.54M | 12.77M | -1.6M | -23.36M | -46.21M | -61.72M | -69.67M | -69.57M | -56.06M | -45.66M | -33.54M | -21.84M | -23.81M | -19.28M | -18.72M | -15.1M | -11.24M | 9.54M | 10.44M | 10.23M | 11.91M | -2.5M |
Capital Expenditures | -810K | -771K | -835K | -866K | -312K | -99K | n/a | -72K | -244K | -267K | -296K | -258K | -114K | -106K | -93K | -76K | -52K | -118K | -102K | -111K | -107K | -22K |
Cash Acquisitions | 42K | 42K | n/a | n/a | n/a | n/a | n/a | -30.4M | 13.88M | 13.88M | 13.88M | 44.28M | n/a | -14.09M | -14.09M | -14.09M | -14.09M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -291.41M | -360.92M | -309.99M | -237.42M | -213.67M | -63.44M | -41.29M | -1.26M | -13.68M | -13.5M | -45.81M | -71.28M | -17.5M | -37.56M | -23.86M | -39.25M | -39.25M | -19.25M | -15.42M | n/a | n/a | n/a |
Sales Maturities Of Investments | 535.19M | 404.47M | 328.5M | 241.2M | 40.71M | 28.21M | 25M | 40.42M | 39.91M | 73.91M | 59.12M | 43.5M | 34.3M | 1.33M | 1.33M | 1.33M | 1.03M | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -56.68M | 44.38M | 448K | 9.51M | 158.92M | 8.92M | -5.87M | -14.79M | -59.08M | -59.08M | -44.28M | -44.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 186.34M | 87.2M | 18.13M | 12.43M | -14.35M | -26.41M | -22.16M | -6.11M | -19.21M | 14.96M | -17.39M | -28.04M | 16.69M | -50.43M | -36.72M | -52.1M | -52.37M | -19.37M | -15.52M | -111K | -107K | -22K |
Debt Repayment | -120.18M | -60.09M | -372K | -16.66M | -16.66M | -372K | n/a | 15.19M | 41.4M | 24.78M | 24.9M | 25.99M | -215K | 12.91M | 12.78M | 12.77M | 12.75M | -122K | -38.1M | -38.14M | -38.17M | -36.18M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.45M | -3.45M | -3.45M | -3.45M | -4.72M | -7.54M | -7.54M | -7.54M | -2.81M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.12M | -2.64M | n/a | 82.98M | 83.07M | 82.18M | 82.18M | -797K | -889K | 1.11M | 692K | 262K | -145K | -516K | -101K | 329K | 1.84M | 36.75M | 99.74M | 99.74M | 98.64M | 62.99M |
Financial Cash Flow | -94.95M | -42.35M | 12.06M | 10.31M | 68.55M | 82.5M | 82.11M | 86.32M | 47.81M | 33.43M | 28.46M | 23.2M | -3.47M | 9.4M | 8.35M | 5.74M | 8.09M | 34.02M | 113.11M | 115.93M | 113.94M | 76.01M |
Net Cash Flow | 130.8M | 58.26M | 28.62M | 400K | 8.45M | -5.51M | -9.26M | 10.77M | -26.94M | 2.67M | -22.42M | -26.79M | -10.58M | -60.03M | -46.85M | -61.41M | -55.49M | 24.22M | 108.02M | 126.24M | 125.93M | 73.67M |
Free Cash Flow | 38.73M | 12M | -2.43M | -24.23M | -46.53M | -61.82M | -69.67M | -69.65M | -56.3M | -45.92M | -33.83M | -22.1M | -23.92M | -19.38M | -18.81M | -15.18M | -11.29M | 9.42M | 10.34M | 10.12M | 11.8M | -2.53M |
Adj. Free Cash Flow | 22.5M | -629K | -15.07M | -36.6M | -62.26M | -77.72M | -84.57M | -83.5M | -65.4M | -54.54M | -41.28M | -26.58M | -27.93M | -22.75M | -22.15M | -19.34M | -15.16M | 6.74M | 7.9M | 8.05M | 9.96M | -4.66M |
Maintenance CapEx | -225K | 27K | 62K | n/a | n/a | n/a | n/a | n/a | -168.71K | -168.71K | -197.71K | -231.71K | -63K | -78K | -65K | -31K | -31K | -16K | n/a | n/a | n/a | 8K |
Growth CapEx | -585K | -798K | -897K | -866K | -312K | -99K | n/a | -72K | -75.29K | -98.29K | -98.29K | -26.29K | -51K | -28K | -28K | -45K | -21K | -102K | -102K | -111K | -107K | -30K |
Owner Earnings | 39.32M | 12.79M | -1.54M | -23.36M | -46.21M | -61.72M | -69.67M | -69.57M | -56.23M | -45.82M | -33.73M | -22.07M | -23.87M | -19.36M | -18.78M | -15.13M | -11.27M | 9.52M | 10.44M | 10.23M | 11.91M | -2.5M |
Add to Watchlist
Select watchlists to add or remove ZVRA